Industry2h ago
Chai Discovery Hits $4B Valuation
Four major AI-pharma tool deals closed during the JPM Pharma conference in San Francisco. Chai Discovery, an OpenAI-backed startup only two years old, now commands a $4B valuation. This surge reflects a pivot in how pharmaceutical companies procure AI capabilities. Practitioners should watch for a trend of tool-based partnerships over traditional drug-discovery ventures.